According to the WHO classification 2014, aberrant p53 staining (diffuse and strong positivity in >75% tumour cells or complete lack of staining) correlates with a TP53 mutation, while variable staining intensity in less than 75% of the tumour cells is related to wild-type TP53 (WHO classification 2014). Here, TP53 is linked to neoplasm.